Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of potential biomarkers and therapeutic targets for cerebral venous thrombosis.

Neurological research - 1 Apr 2026

Song Jiahao, Li Jingrun, Zhang Gaolan, Han Guangyu, Zhang Xiaoming, Ji Xunming, Ding Yuchuan, Zhou Da, Meng Ran

Abstract excerpt

BACKGROUND AND AIMS: Cerebral venous thrombosis (CVT) is an uncommon yet potentially life-threatening subtype of stroke that predominantly affects younger individuals. This study aimed to systematically identify and validate druggable genes associated with CVT susceptibility using Mendelian randomization (MR) approaches. METHODS: We integrated two large-scale expression quantitative trait loci (eQTLs) datasets -...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Genome-Wide Association Study

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Intracranial Thrombosis

Share to Mendelian Randomization Analysis

Share to Molecular Docking Simulation

Share to Polymorphism, Single Nucleotide

Share to Quantitative Trait Loci

Share to Venous Thrombosis

Source

Identifiers

PMID: 40684330
DOI: 10.1080/01616412.2025.2532039

Genes

BMPR2
IL18
COMT
ZP3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of potential biomarkers and therapeutic targets for cerebral venous thrombosis.PMID 40684330Read ↗

Identifying therapeutic target genes for stroke through systematic druggable Mendelian randomization analysis.Semantic proximity Read ↗

Genetic insights into immunothrombosis: from shared loci to repurposed drugs for autoimmune and thrombotic diseasesSemantic proximity Read ↗

Determining Potential Therapeutic Targets for Venous Thrombosis through Network Pharmacology, Cluster Typing, WGCNA, Machine Learning, Immune Infiltration Analysis, and ceRNA NetworksSemantic proximity Read ↗

Venous thromboembolism and severe COVID-19: a Mendelian randomization trial and transcriptomic analysis.Semantic proximity Read ↗

Mendelian Randomization in Stroke: A Powerful Approach to Causal Inference and Drug Target ValidationSemantic proximity Read ↗

Exploration of the causal relationship and mechanisms between serum albumin and venous thrombosis: a bidirectional mendelian randomization analysis and bioinformatics studySemantic proximity Read ↗

Novel Drug Targets for Ischemic Stroke Identified Through Mendelian Randomization Analysis of the Blood ProteomeSemantic proximity Read ↗

Proteome-wide mendelian randomization identifies causal plasma proteins in venous thromboembolism development.Semantic proximity Read ↗

A phenome-wide approach to identify causal risk factors for deep vein thrombosisSemantic proximity Read ↗

Identifying therapeutic target genes for migraine by systematic druggable genome-wide Mendelian randomization.Semantic proximity Read ↗

Inflammatory cytokines are associated with stroke and risk factors of cerebrovascular diseases: a Mendelian randomization study.Semantic proximity Read ↗

Next-generation DNA sequencing to identify novel genetic risk factors for cerebral vein thrombosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.